Abstract #0166

Effects of 3-MPA on in vivo hepatic metabolism of hyperpolarized [1-13C] pyruvate

Emine Can¹, Hikari A.I. Yoshihara^1,2, Jessica A.M. Bastiaansen^1,2, Rolf Gruetter^3,4, and Arnaud Comment¹

¹Institute of Physics, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland, ²Division of Cardiology, University Hospital Lausanne (CHUV), Lausanne, Switzerland, ³Laboratory for Functional and Metabolic Imaging, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland, ⁴Department of Radiology, University of Lausanne (UNIL), Lausanne, Switzerland

Ex vivo and in vivo studies on liver metabolism using hyperpolarized [1-¹³C]pyruvate report do not agree on whether hyperpolarized bicarbonate metabolite production results from pyruvate oxidation or gluconeogenesis. This study tested the ability of hyperpolarized [1-¹³C]pyruvate to probe gluconeogenesis in the liver of intact rats. While conversion to hyperpolarized bicarbonate was detected in the liver of fasted rats, treatment with the phosphoenolpyruvate carboxykinase inhibitor 3-mercaptopicolinc acid resulted in 7-fold lower levels. This result supports the notion that hepatic gluconeogenic metabolism can indeed be directly probed in vivo with hyperpolarized pyruvate.

This abstract and the presentation materials are available to members only; a login is required.

Join Here